PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
about
The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammationColocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.A structure-property relationship study of the well-defined telodendrimers to improve hemocompatibility of nanocarriers for anticancer drug deliveryA smart and versatile theranostic nanomedicine platform based on nanoporphyrin.Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrierTargeted delivery of anticancer agents via a dual function nanocarrier with an interfacial drug-interactive motif.An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistanceA drug-specific nanocarrier design for efficient anticancer therapy."OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer.Perspectives on clinical translation of smart nanotherapeutics.Nanotechnology in bladder cancer: current state of development and clinical practiceSupramolecular nanoparticles generated by the self-assembly of polyrotaxanes for antitumor drug delivery.Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.Reversibly crosslinked nanocarriers for on-demand drug delivery in cancer treatment.Exploring polymeric micelles for improved delivery of anticancer agents: recent developments in preclinical studies.Nanomicellar carriers for targeted delivery of anticancer agents.Targeted liposomal drug delivery systems for the treatment of B cell malignancies.Polymeric micelles: nanocarriers for cancer-targeted drug deliveryIn pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphoma.Polymeric nano-micelles: versatile platform for targeted delivery in cancer.Synthesis and characterization of folate-targeted dextran/retinoic acid micelles for doxorubicin delivery in acute leukemia.Multiscale approach to investigate self-assembly of telodendrimer based nanocarriers for anticancer drug delivery.A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer.Targeted delivery of doxorubicin and vincristine to lymph cancer: evaluation of novel nanostructured lipid carriers in vitro and in vivo.The core-inversible micelles for hydrophilic drug delivery.Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins."One-Pot" Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics.Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer.A facile strategy for fine-tuning the stability and drug release of stimuli-responsive cross-linked micellar nanoparticles towards precision drug delivery.Determination of Doxorubicin in Stealth Hyalurionic Acid-Based Nanoparticles in Rat Plasma by the Liquid-Liquid Nanoparticles-Breaking Extraction Method: Application to a Pharmacokinetic Study.Triolein Emulsion Infusion Into the Carotid Artery Increases Brain Permeability to Anticancer Agents.Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma.Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in adult male albino rats.Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system.pH-degradable and thermoresponsive water-soluble core cross-linked polymeric nanoparticles as potential drug delivery vehicle for doxorubicin
P2860
Q28269056-7969F0D5-74B2-4E3F-BD6C-A6D737A8B506Q28534642-1B86F96F-FFC9-4E1A-AC8A-973FA197A535Q30583249-1D724A86-9E5D-4509-A1BA-0846ECE583FAQ33777178-16717B89-F531-414C-AD46-C4927BD39644Q34093247-16D69472-A662-4323-817B-92BC2E0B3CE8Q34473472-72F968B8-7901-4F8F-BAF5-AE2A3BA0BEF1Q34497005-87AC9B2D-538F-47D3-930E-A64B152F959EQ34714270-442808C8-509E-42C1-9766-2FD6E8A66AC6Q35687060-3BC110AD-85F9-4883-9452-7768E89817F7Q35932503-1791DF5E-81A9-40F2-AE20-3E9A1C2361F9Q35998436-AC7AAC58-8A63-4F70-9FA7-8C744D8CF74BQ36028787-3C64E651-5533-46AA-BC43-E19E6CEC1FD5Q36036029-02EABEC0-4B29-419F-AD2F-4C3791371C79Q36308723-DD0F8AC6-CE55-41C9-B869-CC0717256A17Q36378429-0EF2D67C-5F96-4AB3-B8E3-8C7066860B83Q38074441-5A31682D-19A1-4D55-9DCA-36505982BD35Q38168377-3CD68E5F-97DC-441E-9CC5-53ABD0E95588Q38171564-9CB74EB0-0616-47CD-9370-9994D6D28838Q38179032-6A2BB044-FCB7-4373-94F2-0B9539D6BD2FQ38202058-EF7E18E4-784F-483D-98D7-E08C26826574Q38253121-8C59F216-270D-4C26-B0C9-E3547429FCABQ38270690-5CE853C4-7377-4E67-A884-0495DEF0EE61Q38285591-F81F274A-16B8-443A-B7FD-1BD8CDA3DC48Q38568248-7D12245A-7812-417C-BF89-5B7102AD6799Q38701979-CA7FFF0F-BF08-43E3-B793-30AB50FFC744Q38849688-7924BD9F-AE9E-49D7-8E33-F9A2FD273BC1Q39138378-59E9649E-4C6A-4534-941E-1C261A9DAED8Q41545913-31CC92FE-163D-48C2-8F2D-928A29811358Q41949821-8ACC58E3-AF6D-4CBB-88F8-35A5743AC495Q43273036-11BEBBDF-6FA0-42F6-8C36-A44848D93701Q45988720-D2F2486F-AA7C-41AC-992D-375E13CDE80BQ46342071-BB3F3AA4-EAC6-476B-B2C3-BE13D7ADDC4FQ46355497-8A6F768B-BEBE-4571-BE30-3B2F13F2D00EQ51730066-B2D919F8-B35A-47CD-852D-5E64F6BD6B4AQ52147119-3FD64238-045D-45DC-AB13-4D209DE03651Q52570980-5A98BBF0-36FC-4EF1-90AD-6909C9849DA8Q52887129-260612C1-D36E-4F0A-AEEC-73E24E7B1000Q54942256-7A57BED4-FF49-4EAC-8521-D82F906CBE82Q57368823-6E988BB6-BB8D-4260-A53A-90A8764EC118
P2860
PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
PEG-oligocholic acid telodendr ...... oxorubicin to B-cell lymphoma.
@ast
PEG-oligocholic acid telodendr ...... oxorubicin to B-cell lymphoma.
@en
type
label
PEG-oligocholic acid telodendr ...... oxorubicin to B-cell lymphoma.
@ast
PEG-oligocholic acid telodendr ...... oxorubicin to B-cell lymphoma.
@en
prefLabel
PEG-oligocholic acid telodendr ...... oxorubicin to B-cell lymphoma.
@ast
PEG-oligocholic acid telodendr ...... oxorubicin to B-cell lymphoma.
@en
P2093
P2860
P1476
PEG-oligocholic acid telodendr ...... oxorubicin to B-cell lymphoma.
@en
P2093
Gabriel Fung
Joyce S Lee
Juntao Luo
Yuanpei Li
P2860
P304
P356
10.1016/J.JCONREL.2011.07.018
P407
P577
2011-07-19T00:00:00Z